Ureteral Stents Market Overview
The Ureteral Stents Market focuses on medical devices used to maintain urine flow from the kidneys to the bladder when the ureter is narrowed, blocked, or otherwise compromised. Ureteral stents are thin, flexible tubes placed inside the ureter to relieve obstruction and support urinary drainage. They are commonly used in the management of kidney stones, ureteral strictures, tumors, urinary tract obstructions, kidney transplants, and other urological conditions. Growing adoption of minimally invasive urological procedures and advancements in stent materials and designs are supporting the expansion of the global market.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/1389
Market Drivers
Rising Prevalence of Kidney Stones:
The increasing prevalence of kidney stones is a major factor driving demand for ureteral stents. Kidney stones can obstruct urine flow and often require procedures such as ureteroscopy and lithotripsy, during which ureteral stents may be used to maintain drainage and support recovery.
Growing Incidence of Urological Disorders:
The rising occurrence of ureteral strictures, urinary tract obstructions, urological cancers, and other kidney and urinary disorders is increasing the need for ureteral stenting procedures. As the global burden of urological diseases grows, demand for effective urinary drainage solutions is expected to increase.
Increasing Adoption of Minimally Invasive Procedures:
The growing preference for minimally invasive urological procedures is supporting market growth. Procedures such as ureteroscopy, laser lithotripsy, and endourological interventions frequently utilize ureteral stents, offering patients shorter recovery times and reduced surgical trauma compared with conventional approaches.
Technological Advancements in Stent Design:
Manufacturers are developing advanced ureteral stents using improved polymers, silicone, hydrophilic coatings, anti-encrustation technologies, and biodegradable materials. These innovations are aimed at improving biocompatibility, patient comfort, flexibility, durability, and reducing complications associated with long-term stent placement.
Increasing Healthcare Expenditure:
Growing healthcare expenditure and improving access to urological care are supporting the adoption of ureteral stents. Investments in hospitals, specialty urology centers, diagnostic facilities, and advanced surgical technologies are expanding access to minimally invasive treatments in both developed and emerging economies.
Growing Aging Population:
Older adults have a higher risk of kidney and urinary tract disorders, including kidney stones, ureteral obstruction, and urological cancers. The expanding elderly population is therefore expected to increase demand for diagnostic and therapeutic urological procedures involving ureteral stents.
Market Challenges
Risk of Stent-Related Complications:
Ureteral stents can be associated with complications such as discomfort, urinary frequency, hematuria, infection, migration, and encrustation. These complications can affect patient quality of life and create challenges for healthcare providers.
High Cost of Advanced Stents:
Advanced stents incorporating specialized coatings, drug-delivery capabilities, biodegradable materials, or innovative designs can be more expensive than conventional products. Higher costs may restrict adoption in healthcare systems with limited budgets.
Need for Stent Removal or Replacement:
Many ureteral stents are intended for temporary use and require removal or replacement after a specified period. The need for additional procedures can increase healthcare costs and patient burden while creating demand for stents with improved long-term performance.
Limited Healthcare Access in Emerging Economies:
Limited access to specialized urology services, trained professionals, advanced surgical equipment, and modern healthcare facilities can restrict the adoption of ureteral stents in some developing regions.
Competition from Alternative Treatment Approaches:
Alternative approaches for managing urinary obstruction and kidney stones, including surgical interventions, nephrostomy procedures, and other urinary drainage technologies, can create competitive pressure for ureteral stent manufacturers.
Browse In-depth Market Research Report on Ureteral Stents Market:
https://www.marketresearchfuture.com/reports/ureteral-stents-market-1389
Market Segmentation
By Type:
Double Pigtail Ureteral Stents: Double pigtail or double-J stents feature curled ends designed to help maintain positioning within the kidney and bladder. They are widely used for maintaining urinary drainage following urological procedures.
Open End Stents: Open end stents are designed with an open configuration that facilitates urine drainage and are used in selected urological procedures.
Closed End Stents: Closed end stents feature a closed distal configuration and can be used for specific urinary drainage and postoperative applications.
Multiloop Stents: Multiloop stents are designed to provide additional positioning and stability within the urinary tract and represent an emerging product category.
By Material:
Polymer Stents: Polymer-based stents are widely used because of their flexibility, biocompatibility, and suitability for a broad range of urological procedures.
Silicone Stents: Silicone stents offer flexibility and biocompatibility and may be preferred in applications requiring patient comfort and longer-term placement.
Metallic Stents: Metallic stents provide structural support and are used in selected cases involving persistent or complex ureteral obstruction.
Other Materials: Advanced materials, coatings, and biodegradable polymers are being developed to improve stent performance and reduce complications.
By Treatment/Application:
Kidney Stones: Kidney stone treatment represents an important application for ureteral stents. Stents are frequently used to maintain urine flow before or after stone removal procedures.
Kidney Transplant: Ureteral stents can be used following kidney transplantation to support urinary drainage and healing.
Ureteral Obstruction: Stents are used to bypass obstructions caused by strictures, tumors, stones, or other conditions affecting the ureter.
Other Applications: Additional applications include selected cases involving urinary tract disorders, postoperative drainage, and urological interventions.
By End-User:
Hospitals: Hospitals represent a major end-user segment because they provide advanced diagnostic, surgical, and emergency urological services.
Nephrological Centers: Specialized nephrological and urological centers provide targeted treatment for kidney and urinary tract disorders and contribute to demand for ureteral stents.
Ambulatory Surgical Centers: The increasing adoption of outpatient minimally invasive procedures is supporting the use of ureteral stents in ambulatory surgical centers.
By Region:
North America: North America represents a leading market due to advanced healthcare infrastructure, high adoption of minimally invasive urological procedures, increasing prevalence of kidney stones, and strong presence of major medical device manufacturers.
Europe: Europe is supported by an aging population, established healthcare systems, increasing incidence of urological disorders, and growing adoption of advanced urology technologies.
Asia-Pacific: Asia-Pacific is expected to experience significant growth due to rising healthcare expenditure, improving healthcare infrastructure, increasing awareness of urological diseases, and the growing incidence of kidney stones. China, Japan, and India represent important markets in the region.
Latin America, Middle East & Africa: These regions represent emerging opportunities as healthcare infrastructure improves and access to advanced urological procedures expands.
Regional Insights
North America:
North America is expected to maintain a strong position in the Ureteral Stents Market. The U.S. represents a major market because of its advanced healthcare infrastructure, high procedural volumes, increasing prevalence of kidney stones, and widespread adoption of minimally invasive urological procedures. Strong research and development activities by medical device companies further support innovation in ureteral stent technologies.
Europe:
European countries such as Germany, France, the UK, Italy, and Spain are witnessing continued demand for ureteral stents. Aging populations and increasing healthcare investments are supporting the adoption of modern urological treatment technologies. The region is also focusing on improving minimally invasive procedures and patient-centered urological care.
Asia-Pacific:
Asia-Pacific is expected to represent one of the fastest-growing regional markets. Increasing healthcare expenditure, urbanization, improving hospital infrastructure, and rising awareness of kidney and urinary tract disorders are driving demand. Countries including China, India, Japan, and South Korea are investing in advanced diagnostic and surgical capabilities.
Rest of the World:
Latin America, the Middle East, and Africa are emerging markets for ureteral stents. Improvements in healthcare infrastructure, expansion of specialty hospitals, and increasing access to urological services are expected to create new growth opportunities.
Key Players
Boston Scientific Corporation
Coloplast A/S
Cook Medical
Olympus Corporation
Teleflex Incorporated
Becton, Dickinson and Company (BD)
B. Braun Melsungen AG
Stryker Corporation
UroGen Pharma Ltd.
Merit Medical Systems, Inc.
Future Outlook
The Ureteral Stents Market is expected to experience continued growth through increasing kidney stone prevalence, rising incidence of urological disorders, growing adoption of minimally invasive procedures, and advancements in stent technology. According to Market Research Future, the market was valued at USD 668.0 million in 2025 and is projected to reach USD 1,259.9 million by 2035, registering a CAGR of 6.55% during the 2026–2035 forecast period.
The development of biodegradable stents, advanced anti-encrustation coatings, drug-eluting technologies, and improved biocompatible materials is expected to create new opportunities for manufacturers. The increasing migration of urological procedures toward ambulatory surgical centers and the expansion of healthcare infrastructure in emerging economies are also expected to support market expansion.
Future product development is likely to focus on improving patient comfort, reducing infection and encrustation risks, extending functional performance, and minimizing the need for additional removal procedures. With continued technological innovation and increasing demand for minimally invasive urological care, the market is positioned for sustained development through 2035.
Explore key developments shaping industry transformation:
Healthcare Crm Market Forecast
Healthcare Crm Market Analysis
Healthcare Crm Market Distribution
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing optimal quality and granular research to clients. Its market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country-level market segments enable clients to see more, know more, and do more.
Follow Us: LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
